(Information sent by the signatory company)
Global leader in animal health adopts Veeva Vault Clinical and Veeva Vault RIM for greater efficiency, visibility and speed
BARCELONA, Spain, Feb. 14, 2024/PRNewswire/ — Veeva Systems (NYSE: VEEV) today announced that Boehringer Ingelheim has selected Veeva Vault Clinical and Veeva Vault RIM applications as its technology foundation for clinical and regulatory management at its unit. animal health business. By adopting unified applications on a single platform, Boehringer Ingelheim can optimize clinical execution to accelerate the development of new medicines that help animals live healthier, happier lives.
“Veeva Vault Clinical and Veeva Vault RIM will help us drive greater operational efficiencies across all functions while providing insights for data-driven decision making,” said Marcus Gravendyck, head of global regulatory affairs and Animal Health pharmacovigilance at Boehringer Ingelheim. “This will allow us to execute and innovate faster to improve the lives of animals.”
Boehringer Ingelheim will use Veeva Vault CTMS in its animal health business unit to manage and monitor trials and Veeva Vault eTMF for real-time inspection preparation, visibility and control. The company will also use the Veeva Vault Registrations, Veeva Vault Submissions and Veeva Vault Submissions Archive applications for advanced regulatory processes. Connecting these applications into a single cloud platform will enable real-time access to data and seamless information exchange.
“Boehringer Ingelheim is driving innovation with the goal of accelerating the development of new treatments for animals,” said Thomas Reith, corporate vice president of IT research, development and medicine at Boehringer Ingelheim. “By establishing a centralized, digital foundation with Veeva, we can deliver a better user experience for our teams and deliver end-to-end agile processes for greater speed and agility.”
“We are proud to partner with Boehringer Ingelheim in animal health to simplify their clinical development and regulatory processes,” said Stefan Jahnecke, vice president of animal health strategy at Veeva. “Veeva Vault Clinical and Veeva Vault RIM will help Boehringer Ingelheim increase data integrity, while helping to provide the visibility to quickly adapt to changing business requirements.”
Vault Clinical and Vault RIM are part of the Veeva Development Cloud, the technological foundation for product development in the clinical, regulatory, quality and safety areas. For more information, visit veeva.com/eu/DevelopmentCloud.
About Veeva Systems Veeva is the global leader in cloud software for the life sciences industry. Committed to innovation, product excellence and customer success, Veeva serves more than 1,000 customers, ranging from the world’s largest biopharmaceutical companies to emerging biotechnology companies. As a public benefit corporation, Veeva is committed to balancing the interests of all stakeholders, including customers, employees, shareholders and the industries it serves. For more information visit the website veeva.com/eu.
Veeva Forward-Looking StatementsThis release contains forward-looking statements regarding Veeva’s products and services and the expected results or benefits from the use of our products and services. These statements are based on our current expectations. Actual results could differ materially from those provided in this release and we undertake no obligation to update such statements. There are numerous risks that have the potential to adversely affect our results, including the risks and uncertainties disclosed in our filing on Form 10-Q for the period ended October 31, 2023, which can be found here (a summary of the risks that may affect our business can be found on pages 38 and 39) and in our subsequent filings with the SEC, which can be accessed at sec.gov.
Logo – https://mma.prnewswire.com/media/1488285/Veeva_Systems_Logo.jpg
View original content: https://www.prnewswire.com/news-releases/boehringer-ingelheim-se-asocia-con-veeva-y-avanza-en-sus-operaciones-clinicas-y-normativas-en-salud-animal-302061971.html
